These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 22025774)

  • 1. Nrf2 activators as attractive therapeutics for diabetic nephropathy.
    de Haan JB
    Diabetes; 2011 Nov; 60(11):2683-4. PubMed ID: 22025774
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic potential of Nrf2 activators in streptozotocin-induced diabetic nephropathy.
    Zheng H; Whitman SA; Wu W; Wondrak GT; Wong PK; Fang D; Zhang DD
    Diabetes; 2011 Nov; 60(11):3055-66. PubMed ID: 22025779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulforaphane attenuation of experimental diabetic nephropathy involves GSK-3 beta/Fyn/Nrf2 signaling pathway.
    Shang G; Tang X; Gao P; Guo F; Liu H; Zhao Z; Chen Q; Jiang T; Zhang N; Li H
    J Nutr Biochem; 2015 Jun; 26(6):596-606. PubMed ID: 25724107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of diabetic complications by activation of Nrf2: diabetic cardiomyopathy and nephropathy.
    Li B; Liu S; Miao L; Cai L
    Exp Diabetes Res; 2012; 2012():216512. PubMed ID: 22645602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemistry: A radical treatment.
    Garber K
    Nature; 2012 Sep; 489(7417):S4-6. PubMed ID: 23013714
    [No Abstract]   [Full Text] [Related]  

  • 6. Metallothionein plays a prominent role in the prevention of diabetic nephropathy by sulforaphane via up-regulation of Nrf2.
    Wu H; Kong L; Cheng Y; Zhang Z; Wang Y; Luo M; Tan Y; Chen X; Miao L; Cai L
    Free Radic Biol Med; 2015 Dec; 89():431-42. PubMed ID: 26415026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulforaphane prevents type 2 diabetes-induced nephropathy via AMPK-mediated activation of lipid metabolic pathways and Nrf2 antioxidative function.
    Li Z; Guo H; Li J; Ma T; Zhou S; Zhang Z; Miao L; Cai L
    Clin Sci (Lond); 2020 Sep; 134(18):2469-2487. PubMed ID: 32940670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The protective role of Nrf2 in streptozotocin-induced diabetic nephropathy.
    Jiang T; Huang Z; Lin Y; Zhang Z; Fang D; Zhang DD
    Diabetes; 2010 Apr; 59(4):850-60. PubMed ID: 20103708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cinnamoyl-based Nrf2-activators targeting human skin cell photo-oxidative stress.
    Wondrak GT; Cabello CM; Villeneuve NF; Zhang S; Ley S; Li Y; Sun Z; Zhang DD
    Free Radic Biol Med; 2008 Aug; 45(4):385-95. PubMed ID: 18482591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention by sulforaphane of diabetic cardiomyopathy is associated with up-regulation of Nrf2 expression and transcription activation.
    Bai Y; Cui W; Xin Y; Miao X; Barati MT; Zhang C; Chen Q; Tan Y; Cui T; Zheng Y; Cai L
    J Mol Cell Cardiol; 2013 Apr; 57():82-95. PubMed ID: 23353773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of aldo-keto reductases as NRF2-target marker genes in human cells.
    Jung KA; Choi BH; Nam CW; Song M; Kim ST; Lee JY; Kwak MK
    Toxicol Lett; 2013 Mar; 218(1):39-49. PubMed ID: 23305850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coniferaldehyde attenuates Alzheimer's pathology
    Dong Y; Stewart T; Bai L; Li X; Xu T; Iliff J; Shi M; Zheng D; Yuan L; Wei T; Yang X; Zhang J
    Theranostics; 2020; 10(1):179-200. PubMed ID: 31903114
    [No Abstract]   [Full Text] [Related]  

  • 13. P53/NRF2 mediates SIRT1's protective effect on diabetic nephropathy.
    Ma F; Wu J; Jiang Z; Huang W; Jia Y; Sun W; Wu H
    Biochim Biophys Acta Mol Cell Res; 2019 Aug; 1866(8):1272-1281. PubMed ID: 30959066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NF-E2-related factor 2 and its role in diabetic nephropathy.
    Dadras F; Khoshjou F
    Iran J Kidney Dis; 2013 Sep; 7(5):346-51. PubMed ID: 24072144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of Nrf2 signaling in the regulation of antioxidants and detoxifying enzymes after traumatic brain injury in rats and mice.
    Hong Y; Yan W; Chen S; Sun CR; Zhang JM
    Acta Pharmacol Sin; 2010 Nov; 31(11):1421-30. PubMed ID: 20953205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D activates the Nrf2-Keap1 antioxidant pathway and ameliorates nephropathy in diabetic rats.
    Nakai K; Fujii H; Kono K; Goto S; Kitazawa R; Kitazawa S; Hirata M; Shinohara M; Fukagawa M; Nishi S
    Am J Hypertens; 2014 Apr; 27(4):586-95. PubMed ID: 24025724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cinnamaldehyde Ameliorates Vascular Dysfunction in Diabetic Mice by Activating Nrf2.
    Wang P; Yang Y; Wang D; Yang Q; Wan J; Liu S; Zhou P; Yang Y
    Am J Hypertens; 2020 Jul; 33(7):610-619. PubMed ID: 32242611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SP600125 suppresses
    Zhang H; Liu X; Zhou S; Jia Y; Li Y; Song Y; Wang J; Wu H
    J Mol Endocrinol; 2018 Feb; 60(2):145-157. PubMed ID: 29273684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulforaphane, an activator of Nrf2, suppresses cellular accumulation of arsenic and its cytotoxicity in primary mouse hepatocytes.
    Shinkai Y; Sumi D; Fukami I; Ishii T; Kumagai Y
    FEBS Lett; 2006 Mar; 580(7):1771-4. PubMed ID: 16516206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Keap1/Nrf2/ARE signaling unfolds therapeutic targets for redox imbalanced-mediated diseases and diabetic nephropathy.
    Adelusi TI; Du L; Hao M; Zhou X; Xuan Q; Apu C; Sun Y; Lu Q; Yin X
    Biomed Pharmacother; 2020 Mar; 123():109732. PubMed ID: 31945695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.